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Abstract
We prospectively evaluated 30 consecutive patients with
echo-enhanced transcranial color-coded duplexsonogra-
phy (TCCD) and correlative transfemoral digital subtrac-
tion angiography to assess the diagnostic efficacy of
echo-enhanced TCCD for evaluation of collateral path-
ways through the circle of Willis in patients with limited
acoustic bone windows and critical symptomatic carotid
disease. Echo-enhanced TCCD detected collateral blood
flow through the anterior communicating artery in 16 of
18 patients (sensitivity 89%, 95% CI 65–99%) and was
false positive in one out of 12 patients without collateral
flow (specificity 92%, 95% CI 59–100%). For the posterior
communicating artery, sensitivity was 11/14 (79%, 95%
CI 49–95%) and specificity was 15/16 (94%, 95% CI 70–
100%). Echo-enhanced TCCD enables to study collateral
blood flow through the communicating arteries of the
circle of Willis with high sensitivity and specificity in
patients with obstructions of the internal carotid artery
and limited acoustic bone windows.
Copyright © 2001 S. Karger AG, Basel
Introduction
In patients with severe internal carotid artery (ICA)
stenosis or occlusion, the most important source of collat-
eral flow to the affected hemisphere are the contralateral
ICA and the vertebrobasilar arteries via the communicat-
ing arteries of the circle of Willis [1]. Collateral flow
through the anterior communicating artery (Acom) with
retrograde flow in the A1 segment on the side of carotid
disease depends on an intact anterior half of the circle of
Willis. Many minor variations in the circle of Willis hin-
der this collateral pathways. The vertebrobasilar system
may supply the middle and the anterior cerebral artery
(MCA and ACA) territory through the ipsilateral posteri-
or communicating artery (Pcom). The Pcom is less often
developed than the Acom [2]. Competent collateral flow
has been shown to reduce the risk of subsequent cerebral
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ischemia as well as the risk of ischemia during carotid
endarterectomy and should be analyzed before interven-
tion [3].
In patients with critical carotid stenosis or occlusion,
conventional transcranial Doppler (TCD) is highly sensi-
tive to demonstrate collateral pathways through the circle
of Willis [4, 5]. Digital subtraction angiography (DSA),
however, remains the gold standard for visualization of
the intracranial vasculature. Transcranial color-coded du-
plexsonography (TCCD) is a diagnostic tool that poten-
tially improves ultrasound evaluation of the intracranial
arteries by permitting direct visualization of the vessels, a
feature which is not possible with conventional TCD [6].
Unenhanced TCCD has been shown to be an effective
method for demonstrating collateral pathways in patients
with carotid stenosis [7, 8]. However, thickening of the
temporal bone in stroke age patients, more in women
compared to men and in non-Caucasians, may obviate
detection of the circle of Willis in 20–30% of subjects [9,
10]. Both TCD and TCCD require a good temporal acous-
tic window to insonate the middle cerebral artery (MCA)
and the circle of Willis.
Ultrasound echo-enhancing agents have been success-
fully used to overcome this limitation [11–14]. In this
study, we evaluated the effectiveness of a galactose/pal-
mitic-acid-based echo-enhancing agent (Levovist®; Sche-
ring, Berlin, Germany) for visualizing collateral pathways
through the circle of Willis by TCCD in patients with
hemispheric ischemic symptoms, critical carotid disease
and inadequate acoustic bone windows. Our investigation
was designed to provide the sensitivity and specificity of
echo-enhanced TCCD using DSA as gold standard.
Materials and Methods
We selected all patients during routine stroke work-up in our
institution. All patients had a complete ultrasound evaluation of the
carotid system and a TCCD study. Our routine ultrasound studies
for the carotid system include performance of one indirect noninva-
sive test (periorbital directional Doppler ultrasonography) and of
three direct tests: colorflow imaging, duplex imaging (B-mode/
pulsed-wave Doppler examinations) and continuous-wave Doppler
ultrasonography.
Patients eligible for inclusion into the study had to fulfill two
main criteria. (1) Critical symptomatic carotid stenosis with 690%
lumen diameter reduction (corresponding to a residual lumen diame-
ter ^1.0 mm) or carotid occlusion. In this patient group, the ob-
structed ICA does not supply any significant flow volume to the
affected hemisphere. Therefore, these patients completely depend on
collateral flow to the affected hemisphere and may serve as a model
for evaluation of collateral flow through the circle of Willis [15].
(2) No detectable colorflow signals of the circle of Willis by unen-
hanced TCCD due to limited acoustic windows. One of three inde-
pendent experienced investigators (G.G., S.H.-E., G.H.) made the
diagnosis of limited bone windows.
During the period from January 1997 to December 1999, we
enrolled 30 consecutive patients (7 women, 23 men, mean age 63.8
B 12.1) into the study. Twenty-eight patients had unilateral disease
(16 stenoses, 12 occlusions), 2 patients had bilateral disease (1 bilat-
eral occlusion, 1 occlusion on one side and critical stenosis on the
other). We evaluated 17 patients during normal work-up for a recent
ischemic event. In these patients, the mean time interval between
onset of cerebral ischemia and echo-enhanced TCCD/DSA was 2.84
B 3.27 days, 9/17 patients were evaluated within 24 h. The remain-
ing patients had a remote ischemic event on the side of the carotid
disease within the last 6 months.
TCCD Examination
Echo-enhanced TCCD was performed by three experienced phy-
sicians (G.G., S.H.-E., G.H.), details of the examination procedure
are described elsewhere [16]. Four patients received two bolus injec-
tions of the echo-enhancing agent (2 ! 2.5 g Levovist, concentration
300 mg/ml), the remaining a single continuous infusion of 4 g Levo-
vist (concentration 300 mg/ml) over 5 min, which was found to pro-
vide better colorflow data because of a less prominent ‘blooming
effect’. The blooming effect causes echoes from moving blood to spill
over vessel wall margins and creates overblown caricatures of the
vascular pathways [17]. Continuous infusion of the microbubble
echo-enhancing agent provides prolonged and uniform enhancement
of Doppler signals and improves image quality by minimizing satura-
tion artifacts [18]. Both sides of the circle of Willis were evaluated
separately through each temporal window. In a first step, the examin-
er tried to identify all branches of the circle of Willis including the
M1, A1 and A2, as well as the P1 and the P2 segments of the MCA,
ACA and the posterior cerebral artery (PCA), respectively. For the
evaluation of collateral flow, we analyzed colorflow signals according
to flow direction and turbulence in the A1 segments of the ACA. We
also analyzed the P1 segments of the PCA and the Pcom for turbulent
flow. We further evaluated these vascular segments with duplex spec-
tral waveform analysis. The TCCD diagnosis of collateral flow
through the Acom was based on the detection of retrograde flow in
the A1 segment on the side of the carotid disease. The diagnosis of
collateral flow through the Pcom was based either (1) on the com-
bined findings of visual detection of the artery itself and turbulent
flow in this segment or (2) on the visual detection of the artery itself
without turbulent flow in this segment, but with turbulent flow in the
P1 segment of the side of carotid obstruction.
The examiner was blinded to the results of DSA. All echo-
enhanced TCCD studies were recorded on super VHS videotape.
Ultrasound examinations were performed with an AUCSON
128XP/4 with a 2.0/2.5-MHz transcranial sector scanner device. All
TCCD data were analyzed off-line by two independent investigators
(G.G., G.H.) blinded to the results of the DSA results. The analyses
were then compared, and, if disagreements were found, the data were
reviewed collaboratively to reach a final consensus.
DSA
All patients underwent DSA as correlative imaging studies. DSA
were performed and read by 3 neuroradiologists (T.S., H.B., R.v.K.)
blinded to the results of the echo-enhanced TCCD. All patients
underwent four-vessel angiography for evaluation of all collateral
pathways. Anatomic information recorded on a standardized data
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collection sheet included the site of carotid obstruction and the mea-
surement of stenosis in ipsilateral and contralateral carotid arteries.
Measurements of stenoses were expressed as percent stenosis of
the narrowest luminal diameter relative to the diameter of the distal
ICA. Whether there was collateral flow present through the Acom or
through Pcom was documented in a dichotomous way both for
TCCD and DSA studies. As for the TCCD analyses, different find-
ings were reviewed collaboratively to reach a final consensus. The
mean time interval between DSA and TCCD was 2.7 B 2.5 days.
Results
In all patients, echo-enhanced TCCD enabled full
visualization of the circle of Willis bilaterally. The mean
duration of echo-enhancement after continuous infusion
was 6 min 55 s with a range of 3 min 5 s to 10 min 40 s. In
the patients with bolus injections, the duration was 2 min
45 s to 5 min 55 s.
In 18/30 patients, DSA showed collateral flow through
the Acom (fig. 1c), which was visualized by echo-en-
hanced TCCD in 16 patients (89% sensitivity; fig. 1a, b).
Echo-enhanced TCCD was correct in 11/12 patients, in
whom DSA showed no collateral flow through the Acom
(92% specificity).
Echo-enhanced TCCD identified 11/14 patients with
angiographically proven collateral flow through the Pcom
(79.0% sensitivity; fig. 1a, b, d). In 16 patients, DSA did
not show collateral flow through the Pcom, which was sug-
gested by echo-enhanced TCCD in 15 patients (94% spec-
ificity; table 1).
In 1 patient with unilateral carotid occlusion, TCCD
showed increased flow velocities in the Pcom, which was
taken as evidence for collateral flow through the Pcom.
DSA, however, documented a hypoplastic Pcom which
did not contribute significant flow to the MCA territory.
Disagreements between DSA and echo-enhanced
TCCD concerning the determination of collateral flow
through the Acom by TCCD occurred in 2 patients. In
one of these with a unilateral ICA occlusion, slight vertical
tilting of the ultrasound probe led to different flow direc-
tions in a region where one would typically expect to find
the A1 segment. Depending on the probe position, the A1
on the side of stenosis appeared to be retro- or antegrade
(fig. 2a–d). There were no increased blood flow velocities
detectable in the contralateral A1. However, by insona-
tion from the contralateral side, there was obvious retro-
grade flow through the A1 segment on the side of the
carotid occlusion. By DSA, the A1 was obviously retro-
grade, but formed a loop at its origin from the ICA. In this
selected patient, the close spatial relationship between the
Table 1. Echo-enhanced TCCD findings compared to DSA
Acom % 95% CI Pcom % 95% CI
Sensitivity 16/18 89 65–99 11/14 79 49–95
Specificity 11/12 92 59–100 15/16 94 70–100
Accuracy 27/30 90 73–98 26/30 87 69–96
Acom/Pcom: collateral flow through the Acom/Pcom.
two arms of the A1 segment may have caused the confus-
ing TCCD findings. Additionally the blooming effect may
worsen differentiation between vessels by disrupting ves-
sel borders.
In the 2 patients with bilateral carotid artery occlusion,
TCCD detected collateral flow through the Pcom bilater-
ally, confirmed by DSA. However, in one of these pa-
tients, DSA suggested also additional retrograde flow in
one A1 segment. There were no early films available for
verification. The echo-enhanced TCCD showed bilateral
antegrade A1 segments, and both ultrasound readers felt
highly confident with their findings.
No serious adverse events occurred after application of
Levovist.
Discussion
Transcranial ultrasound, both TCD and TCCD, are
powerful tools for the assessment of collateral flow
through the circle of Willis. In patients with acute hemi-
spheric ischemic events, ultrasound studies of intracrani-
al hemodynamics can provide important information.
Similarly, in patients with subacute or chronic events,
transcranial ultrasound could be used to define the type of
ischemic injury.
Acoustical bone windows of stroke patients may be
limited or nonexistent, restricting the applicability of rou-
tine transcranial ultrasound. Our patients had either se-
vere ICA stenosis or occlusion. Echo-enhanced TCCD
showed the circle of Willis on the side of concern in all
subjects who had no identifiable intracranial vessels in the
unenhanced study.
We found echo-enhanced TCCD to be highly effective
for evaluation of collateral blood flow in critical carotid
obstruction. Disagreements between echo-enhanced
TCCD and DSA may be explained by the blooming effect
[17]. The blooming effects of the echo-enhancing agent
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Fig. 1. a Echo-enhanced TCCD in a patient with unilateral ICA ste-
nosis suggesting collateral flow through the Acom and the Pcom (for
orientation see b). The arrow points to the A1 segment on the side of
ICA obstruction. The red colorflow signal in this segment indicates
retrograde flow directed to the side of ICA obstruction. Normally,
flow in this segment would be directed towards the midline encoded
by a bue colorflow signal. Note the turbulent flow in 3 arterial seg-
ments (short arrows): (1) in the A1 segment contralateral to the side
of carotid obstruction; (2) on the side of carotid obstruction in the P1
segment, and (3) in the Pcom, suggesting collateral flow through these
vessels. c/d Corresponding DSA (anteroposterior and lateral view)
confirming collateral flow through the Acom and Pcom.
Fig. 2. Disagreement between echo-enhanced TCCD and DSA.
a Echo-enhanced TCCD shows red-coded colorflow signal in the A1
segment on the side of carotid stenosis suggesting retrograde flow in
this segment (arrow). b Slight vertical tilting of the ultrasound trans-
ducer shows blue-coded colorflow signal suggesting an antegrade flow
in the A1 segment (arrow) on the side of stenosis. c Insonation from
the contralateral side identifies only retrograde flow signals suggest-
ing collateral flow from the normal side to the side of carotid obstruc-
tion (arrow). Note the ‘blooming effect’ which causes echoes from
moving blood to spill over vessel wall margins and creates overblown
caricatures of the vascular pathways. This artifact impairs visual
identification of the arterial segments. d DSA demonstrates retro-
grade flow on the side of stenosis (arrow). There is marked tortuousi-
ty of the A1 segment which may, in combination with the blooming
effect, explain the confusing colorflow signals in this vessel segment.
causes anatomical disruption of the vessel borders. This
phenomenon impairs the anatomical resolution of the col-
orflow data and may lead to uncertainties in vessel identi-
fication. Figure 2 illustrates this assumption in a patient
with a tortuous vessel segment, in whom slight vertical
tilting of the ultrasound probe led to different colorflow
findings. In another patient with bilateral carotid artery
occlusion, we did not find an explanation for the differ-
ences between echo-enhanced TCCD and DSA findings.
In this patient, DSA did not provide sufficient data to
confirm retrograde flow through the left A1 segment. We
interpreted complete filling of both A1 segments without
filling of the A2 segments and slightly delayed filling of
the left MCA on the earliest available film as evidence for
a retrograde left A1 segment. Echo-enhanced TCCD un-
doubtedly showed bilateral antegrade A1 segments. How-
ever, we performed the ultrasound study 5 days after the
DSA. In the interim, sufficient collateral flow through the
left Pcom may have developed to also provide antegrade
flow through the left A1 segment. Another reason might
be a misinterpretation of the DSA. DSA only provides
one set of real-time data during the procedure, afterwards
data analysis is based on single films. Since echo-
enhanced TCCD provides continuous real-time data
stored on video tape, it may better allow assessment of
dynamic flow processes.
In a typical stroke population, Levovist can increase
the sensitivity of TCCD to detect the circle of Willis from
71.3 to 91.6% [19]. In our patient group, we had no
patient in whom Levovist failed to detect the circle of Wil-
lis. We evaluated predominantly male patients. The prev-
alence of 1 80% carotid stenosis is twice as high in males
than in females, which explains the sex distribution in our
study [20]. Since the acoustic bone windows are generally
better in males than in females, the sex relationship of our
patients may have contributed to the good effect of Levo-
vist. Otherwise we would have expected Levovist to fail in
some patients with respect to visualization of the entire
circle of Willis. Another reason for its good effect could be
the relative young age of 63.8 B 12.1 years in our patient
group. As a university hospital, we may not see a typical
stroke-aged population, but relatively younger patients.
In their study with unenhanced TCCD Baumgartner et
al. found a sensitivity of 98% and a specificity of 100% for
detection of collateral flow through the Acom, and 84%
sensitivity and 94% specificity for the Pcom [8]. These
values are higher than ours, which might be related to the
blooming effect of the echo-enhancing agent.
Martin et al. [7] did not correlate their unenhanced
TCCD findings with DSA; they found collateral flow pat-
terns in only 60% of patients with critical carotid stenosis
or occlusion. By echo-enhanced TCCD and by DSA, we
had 8 patients without detectable collateral flow through
the Acom or Pcom, which correlates with anatomical
studies [2].
A draw back of the echo-enhancing agent is the short
half-time in the circulation when given as a bolus injec-
tion. When using the continuous infusion technique rath-
er than the bolus injection, the recorded duration of echo-
enhancement was sufficiently long to evaluate the entire
circle of Willis from both sides of the skull.
Alternative noninvasive techniques for evaluation of
the circle of Willis are spiral CT angiography and MR
angiography. Direction of flow cannot be displayed by
spiral CT angiography, which limits its applicability to
evaluation of collaterals. MR angiography, however, is
able to demonstrate the direction of flow with phase con-
trast sequences [21].
Because echo-enhanced TCCD can be done safely by
the bedside even in uncooperative patients, it appears a
sound and reliable examination for patients with severe
carotid disease in the acute stroke phase. Prior to endar-
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terectomy, echo-enhanced TCCD may help to avoid using
angiography. Echo-enhanced TCCD is a promising tech-
nology, but needs further refinement before it is of clinical
value.
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